Results 111 to 120 of about 44,493 (220)

Post‐Therapeutic Dosimetry of Metastatic Castration‐Resistant Prostate Cancer With 177Lu‐PSMA: Experiences From Two University‐Based Hospitals in Thailand

open access: yesAsia-Pacific Journal of Clinical Oncology, Volume 22, Issue 2, Page 199-206, April 2026.
ABSTRACT Objective 177Lu‐PSMA radioligand therapy (RLT) is increasingly used to treat metastatic castration‐resistant prostate cancer (mCRPC). Posttreatment dosimetry is essential for assessing normal organ absorbed doses. Therefore, this study aims to evaluate normal organs dosimetry in mCRPC patients undergoing 177Lu‐PSMA‐RLT from two university ...
Onnicha Pattanawong   +6 more
wiley   +1 more source

What Is Your Diagnosis? Submandibular Mass in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Whitney K. Chandler   +3 more
wiley   +1 more source

Automatic target volume segmentation for offline adaptive head–and‐neck radiotherapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 3, March 2026.
Abstract Purpose To assess the clinical utility of Smartfuse (Therapanacea, France), a deformable image registration (DIR) algorithm for automatic propagation of target volumes in the context of offline adaptive head‐and‐neck radiotherapy. Materials and methods Ten patients underwent offline re‐planning during head‐and‐neck radiotherapy. Target volumes
Gilles Moliner   +6 more
wiley   +1 more source

Generalizability of deep learning–based dose conversion model in proton beam therapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 3, March 2026.
Abstract Background In proton beam therapy (PBT), the analytical pencil beam (PB) algorithm involves dose uncertainties in inhomogeneous regions, making accurate Monte Carlo (MC) dose calculation desirable but time‐consuming. Deep learning, converting the dose calculated by the PB algorithm into an MC‐equivalent dose distribution, can resolve the trade‐
Ryohei Kato   +6 more
wiley   +1 more source

Isocenter Optimization in WBRT: Concurrent Sparing of Lens and Lacrimal Gland via Anterior Penumbra Sharpening

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 3, March 2026.
Abstract Background With improving survival for patients receiving whole‐brain radiotherapy (WBRT), mitigating long‐term toxicities like cataract and dry eye syndrome has become increasingly critical. The lens and lacrimal gland are highly radiosensitive and lie in close proximity to the target volume, posing a persistent challenge for achieving sharp ...
Chen Xie   +5 more
wiley   +1 more source

Primary squamous cell carcinoma of the parotid gland: A rare case with diagnostic challenges. [PDF]

open access: yesRadiol Case Rep
Bouallou M   +5 more
europepmc   +1 more source

Pattern and Clinical Significance of CA19‐9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Carbohydrate antigen 19–9 (CA19‐9) is a cell surface glycoprotein widely used as a diagnostic and prognostic serum marker for monitoring pancreatic cancer. The aim of this study was to evaluate the prevalence and clinical relevance of CA19‐9 expression in human cancer. Methods To comprehensively determine the prevalence and clinical
Nina Schraps   +31 more
wiley   +1 more source

Iodide Mumps Following Facial Iodine Iontophoresis: A Case Report. [PDF]

open access: yesInt Med Case Rep J
Mai W   +5 more
europepmc   +1 more source

Long‐Term Survival Outcomes of Concurrent Chemoradiotherapy for Postoperative High‐Risk Salivary Gland Carcinomas

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background This study evaluated the long‐term survival outcomes of concurrent chemoradiation (CCRT) for high‐risk salivary gland carcinomas (SGCs). Method Postoperative patients with high‐risk SGCs, other than adenoid cystic carcinoma (ACC), with T3‐4/N1‐3M0 disease were enrolled.
Shengjin Dou   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy